(VIANEWS) – KENMARE RESOURCES (KMR.IR), PHOTOCURE (PHO.OL), SMURFIT KAPPA GP (SK3.IR) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| KENMARE RESOURCES (KMR.IR) | 12.25% | 2023-11-14 08:22:36 |
| PHOTOCURE (PHO.OL) | 5.95% | 2023-11-14 08:42:10 |
| SMURFIT KAPPA GP (SK3.IR) | 4.66% | 2023-11-14 08:22:46 |
| SANOFI (SAN.PA) | 4.18% | 2023-11-14 09:22:08 |
| INDLE FIN.ENTREPR. (INFE.PA) | 3.39% | 2023-11-12 07:46:44 |
| THALES (HO.PA) | 2.08% | 2023-11-14 09:23:34 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. KENMARE RESOURCES (KMR.IR)
12.25% Foward Dividend Yield
KENMARE RESOURCES’s last close was €4.48, 21.4% under its 52-week high of €5.70. Intraday change was 0.89%.
Kenmare Resources plc, together with its subsidiaries, produces and sells mineral sand products in China, the rest of Asia, Europe, the United States, and internationally. It operates the Moma Titanium Minerals Mine located on the northeast coast of Mozambique. The company's products include ilmenite, rutile, and zircon; and concentrates, including secondary zircon and mineral sand concentrates. As of December 31, 2022, it had a total proved and probable ore reserves of 1,507 million tons. The company was formerly known as Kenmare Oil Exploration plc and changed its name to Kenmare Resources plc in 1987. Kenmare Resources plc was incorporated in 1972 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, KENMARE RESOURCES has a trailing twelve months EPS of €2.03.
PE Ratio
KENMARE RESOURCES has a trailing twelve months price to earnings ratio of 2.23. Meaning, the purchaser of the share is investing €2.23 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.17%.
More news about KENMARE RESOURCES.
2. PHOTOCURE (PHO.OL)
5.95% Foward Dividend Yield
PHOTOCURE’s last close was kr52.70, 54.17% below its 52-week high of kr115.00. Intraday change was -0.38%.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PHOTOCURE has a trailing twelve months EPS of kr-1.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.1%.
Moving Average
PHOTOCURE’s worth is under its 50-day moving average of kr53.07 and way below its 200-day moving average of kr58.97.
Sales Growth
PHOTOCURE’s sales growth for the next quarter is 12%.
More news about PHOTOCURE.
3. SMURFIT KAPPA GP (SK3.IR)
4.66% Foward Dividend Yield
SMURFIT KAPPA GP’s last close was €32.23, 19.77% under its 52-week high of €40.17. Intraday change was -1.77%.
Smurfit Kappa Group plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in the Americas and Europe. The company offers e-commerce, retail, consumer, industrial, bottle, protective, heavy-duty, hexacomb, and various punnet packaging products; composite cardboard tubes, bags, and sacks; and bag-in-box, a packaging system that comprises films, accessories, bags, taps, and boxes. It also provides point of sale displays; cardboards of social distancing; corrugated sheet boards, solid board sheets, folding carton sheet boards, sack Kraft papers, MG brown Kraft papers, preprint products, agro-papers, technical papers, BanaBag, and Catcher Board MB12; various types of containerboards, such as Kraftliners, testliners, and containerboard flutings; and solid board sheets. In addition, the company offers recycling solutions to cardboard and paper products; and supplies packaging machinery. It primarily serves consumer goods, industrial goods, and food and drink sectors. Smurfit Kappa Group plc was founded in 1934 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, SMURFIT KAPPA GP has a trailing twelve months EPS of €3.24.
PE Ratio
SMURFIT KAPPA GP has a trailing twelve months price to earnings ratio of 9.77. Meaning, the purchaser of the share is investing €9.77 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.28%.
Volatility
SMURFIT KAPPA GP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.01%, a positive 0.05%, and a positive 1.45%.
SMURFIT KAPPA GP’s highest amplitude of average volatility was 1.08% (last week), 1.18% (last month), and 1.45% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.6%, now sitting on 12.27B for the twelve trailing months.
Moving Average
SMURFIT KAPPA GP’s value is under its 50-day moving average of €33.28 and below its 200-day moving average of €34.29.
More news about SMURFIT KAPPA GP.
4. SANOFI (SAN.PA)
4.18% Foward Dividend Yield
SANOFI’s last close was €85.29, 18.91% below its 52-week high of €105.18. Intraday change was -0.46%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €7.22.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 11.76. Meaning, the purchaser of the share is investing €11.76 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SANOFI’s stock is considered to be overbought (>=80).
More news about SANOFI.
5. INDLE FIN.ENTREPR. (INFE.PA)
3.39% Foward Dividend Yield
INDLE FIN.ENTREPR.’s last close was €95.00, 35.71% higher than its 52-week high of €70.00. Intraday change was 70.27%.
Compagnie Industrielle et Financière d'Entreprises SA operates as a construction company in France. It undertakes maritime and river, underwater, structures and civil engineering, buildings, and other special works. The company also develops real estate properties. Compagnie Industrielle et Financière d'Entreprises SA was founded in 1913 and is headquartered in Saint-Herblain, France. The company is a subsidiary of Alfred de Musset SAS.
Earnings Per Share
As for profitability, INDLE FIN.ENTREPR. has a trailing twelve months EPS of €4.78.
PE Ratio
INDLE FIN.ENTREPR. has a trailing twelve months price to earnings ratio of 19.77. Meaning, the purchaser of the share is investing €19.77 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.21%.
Yearly Top and Bottom Value
INDLE FIN.ENTREPR.’s stock is valued at €94.50 at 16:50 EST, way higher than its 52-week high of €70.00.
More news about INDLE FIN.ENTREPR..
6. THALES (HO.PA)
2.08% Foward Dividend Yield
THALES’s last close was €141.10, 3.16% below its 52-week high of €145.70. Intraday change was -1.35%.
Thales S.A. provides various solutions for civilian and military customers in the defence and security, aerospace and space, digital identity and security, and transport markets worldwide. It operates through Aerospace, Defence & Security, Digital Identity & Security, and Ground Transportation Systems business segments. The company offers communications, command, and control systems; mission services and support; protection and mission/combat systems; surveillance, detection, and intelligence systems; training and simulation solutions for air, land, naval, and joint forces; and digital identity and security solutions. It also provides air traffic management solutions; flight decks and avionics equipment and functions; in-flight entertainment and connectivity systems and services; electrical systems; aerospace trading solutions; navigation solutions; support and services for avionics equipment; and connectivity solutions. In addition, the company designs, operates, and delivers satellite-based systems for telecommunications, navigation, earth observation, environmental management, exploration, and science and orbital infrastructures; signaling, communications and supervision, and fare collection management systems and related services; cybersecurity and railway digitalization systems; and main line rail, and urban and intermodal mobility solutions. Further, it provides solutions for various markets and applications, including radiology, radio frequency, microwave sources, training and simulation solutions, lasers, and microelectronics solutions for science, industry, space, defense, automotive, railways, and energy conversion platforms. The company was formerly known as Thomson-CSF and changed its name to Thales S.A. in 2000. Thales S.A. was founded in 1893 and is headquartered in Courbevoie, France.
Earnings Per Share
As for profitability, THALES has a trailing twelve months EPS of €5.59.
PE Ratio
THALES has a trailing twelve months price to earnings ratio of 24.9. Meaning, the purchaser of the share is investing €24.9 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.78%.
Moving Average
THALES’s value is higher than its 50-day moving average of €136.31 and higher than its 200-day moving average of €133.65.
More news about THALES.
